Filing metadata

Accession number
0000950170-24-084299
Form type
Form 4
Filer
SAB Biotherapeutics, Inc.
CIK
CIK 1833214
Filed
Jul 17, 2024
Reporting period
Jul 15, 2024
Description
Insider transaction

Explore SEC Filings Hub